Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Patent
1995-05-31
1997-02-18
Marx, Irene
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
4352529, 435854, 426 61, 426583, 426584, 426588, 426580, C12N 120, A01N 6308
Patent
active
056039301
ABSTRACT:
Lactobacillus johnsonii strain CNCM I-1225 adheres to Caco-2 cells and inhibits adhesion thereto by enterovirulent and enteroinvasive pathogens.
REFERENCES:
patent: 3953609 (1976-04-01), Farr
patent: 4147773 (1979-02-01), Ogasa
patent: 4314995 (1982-02-01), Hata et al.
patent: 4332790 (1982-09-01), Sozzi et al.
patent: 4396631 (1983-03-01), Adachi et al.
patent: 4689226 (1987-08-01), Numri et al.
patent: 4921857 (1990-05-01), Heck et al.
patent: 4946791 (1990-08-01), Manfredi et al.
patent: 4980164 (1990-12-01), Manfredi et al.
patent: 4985246 (1991-01-01), Okonogi et al.
patent: 5032399 (1991-07-01), Gorbach et al.
patent: 5116821 (1992-05-01), Randall et al.
patent: 5229380 (1993-07-01), Harris
patent: 5296221 (1994-03-01), Mitsuoka
Prescott & Dunn's, "Industrial Microbiology", 4th ed. 1982, Avi Publ. Co.
Patent Abstracts of Japan (vol. 13, No. 579): JP-A-12 42 532, Yakult Honsha Co. Ltd., Sep. 27, 1989.
Berg & Savage, Immune Responses of Specific Pathogen and Gnotobiotic Mice in Antigens of Indigenous and Nonindigenous Microorganisms. Infection and Immunity, vol. 11, Feb. 1975, pp. 320-329.
Biological Abstract No. 252134 (vol. 79): Ducluzeau, et al., Transfer of the Fecal Microbial Flora from Holoxenic Piglets and Adult Pigs to Axenic Piglets and Axenic Adult Mice; Effect of the Animal Host and of the Diet on the Fecal Microbial Pattern of these Animals. Ann Microbial (Paris) 1978, pp. 597-612.
Shahani, et al., Role of dietary lactobacilli in gastrointestinal microecology. The American Journal of Clinical Nutrition, vol. 33, Nov. 1980, pp. 2448-2457.
Perdigon, et al., Actividad Inmunopotenciadora de Bacterias Lacticas Administradas por via oral. Medicina (Buenos Aires). 46 (1986): 751-754.
Hotta, et al., Clinical Effects of Bifidobacterium Preparations on Pediatric Intractable Diarrhea. Keio J. Med., pp. 298-314, 1987.
Silva et al., Antimicrobial Substance from a Human Lactobacillus Strain. Antimicrobial Agents and Chemotherapy. Aug., 1987, 31(8), pp. 1231-1233.
Perdigon, et al., Systemic Augmentation of the Immune Response in Mice by Feeding Fermented Milks with Lactobacillus case; and Lactobacillus acidophilus, Immunology 63 (1988): pp. 17-23.
Driessen, et al., Fermented Milks with Selected Intestinal Bacteria: a healthy trend in new products, Neth. Milk Dairy J. 43 (1989) 367-382.
Bhatia, et al., Lactobacillus acidophilus Inhibits Growth of Campylobacter pylori In Vitro, Journal of Clinical Microbiology, vol. 27, No. 10, pp. 2328-2330 (1989).
Perdigon, et al., Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus. Journal of Dairy Research, 57, (1990), 255-264.
Goldin, et al., Survival of Lactobacillus Species (Strain GG) in Human Gastrointestinal Tract, Digestive Diseases and Sciences. vol. 37, No. 1 (Jan. 1992) pp. 121-128.
Medline Database Abstract No. 92253433: Balli, et al., Batterioterapia orale ad alte dosi nella diarrea cronica aspacificia del bambino. Pediatr Med Chir (Italy). Jan.-Feb. 1992, 14(1), pp. 13-15.
Chauvi ere, et al., Adhesion of human Lactobacillus acidophilus Strain LB to Enterocyte-Like Caco-2 Cells. Journal of General Microbiology, 138 1689-1696 (1992).
Bazzoli, et al., In Vivo Helicobacter pylori Clearance Failure with Lactobacillus acidophilus. Gastroenterology, vol. 102, No. 4, Part 2, AGA Abstracts pp. A38 (1992).
Coconnier, et al., Protein-Mediated Adhesion of Lactobacillus acidophilus BG2F04 on Human Enterocyte and Mucus-Secreting Cell Lines in Culture. Applied and Environmental Microbiology, vol. 58, No. 6, pp. 2034-2039 (1992).
Chauvi ere, et al., Competitive exclusion of diarrheagenic Escherichia coli (EtEC) from human enterocyte-like Caco-2 cells by heat killed Lactobacillus. FEMS Microbiology Letters 91:213-218 (1992).
Midolo, et al., Lactobacilli and Related Organisms have Activity Against Helicobacter pylori In Vitro. Gastroenterology, vol. 104, No. 4, Part 2. AGA Abstracts p. A746 (1993).
Lidbeck, et al., Lactobacilli, anticarcinogenic activities and human intestinal microflora. European Journal of Cancer Prevention. vol. 1:341-53 (1992).
Gonzalez, et al., Inhibition of Enteropathogens by Lactobacilli Strains Used in Fermented Milk. Journal of Food Protection, vol. 56, No. 9 pp. 773-776 (Sep. 1993).
Coconnier, et al., Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiology Letters 110:299-306 (1993).
Nader de Macias, Prevented of Infections Produced by Escherichia coli and Listeria monocytogenes by Feeding Milk Fermented with Lactobacilli. Journal of Food Protection vol. 56, No. 5 pp. 401-405 (1993).
Brassart Dominique
Donnet Anne
Link Harriet
Mignot Olivier
Neeser Jean-Richard
Marx Irene
Nestec S.A.
LandOfFree
Lactobacillus johnsonii CNCM I-1225 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactobacillus johnsonii CNCM I-1225, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactobacillus johnsonii CNCM I-1225 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1600784